Literature DB >> 8044800

Cloning and sequence analysis of the promoter region of the MRP gene of HL60 cells isolated for resistance to adriamycin.

Q Zhu1, M S Center.   

Abstract

Non-P-glycoprotein multidrug resistance of HL60/ADR cells appears to be related to overexpression of the MRP gene. Recent studies suggest that this gene may play an important role in a new form of cell resistance to certain chemotherapeutic agents. To examine mechanisms regulating transcriptional activity of this gene, a 2.2-kilobase 5'-flanking sequence of MRP has been isolated from a genomic library prepared from HL60/ADR cells. The 2.2-kilobase DNA fragment linked to the chloramphenicol acetyltransferase (CAT) gene in a reporter plasmid was found to be capable of driving expression of this gene in transient transfection experiments. This DNA containing promoter activity has been sequenced in its entirety and found to contain multiple putative regulatory sites. A series of deletion mutants linked to the CAT reporter gene was used to examine functional domains of the 2.2-kilobase sequence. The results suggest that promoter activity is contained in nucleotides -91 to +103 in a GC-rich region of the MRP genome. Promoter activity contained within this sequence, however, is modulated by both positive and negative regulatory elements. Certain of the regulatory sites contain consensus sequences for positive and negative regulatory elements which have been found in the promoter regions of other genes. Primer extension analysis indicates the presence of multiple major transcriptional start sites from the MRP promoter. Sequence analysis of MRP genomic and complementary DNAs has defined the exon/intron boundaries and the organization of a portion of the 5'-end region of the MRP genome. The results of these studies thus provide new insight in site-specific domains which may function in the regulation of MRP gene expression.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8044800

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  21 in total

1.  Promoter polymorphism of MRP1 associated with reduced survival in hepatocellular carcinoma.

Authors:  Jing Zhao; Bing-Yun Yu; Dao-Yuan Wang; Jin-E Yang
Journal:  World J Gastroenterol       Date:  2010-12-28       Impact factor: 5.742

2.  Characterization of the rat mdr2 promoter and its regulation by the transcription factor Sp1.

Authors:  P C Brown; J A Silverman
Journal:  Nucleic Acids Res       Date:  1996-08-15       Impact factor: 16.971

3.  HNF4alpha and NF-E2 are key transcriptional regulators of the murine Abcc6 gene expression.

Authors:  Vanessa Douet; Christopher M VanWart; Matthew B Heller; Sabrina Reinhard; Olivier Le Saux
Journal:  Biochim Biophys Acta       Date:  2006-08-11

Review 4.  Portrait of multifaceted transporter, the multidrug resistance-associated protein 1 (MRP1/ABCC1).

Authors:  Eva Bakos; László Homolya
Journal:  Pflugers Arch       Date:  2006-12-23       Impact factor: 3.657

Review 5.  Regulation of hepatic ABCC transporters by xenobiotics and in disease states.

Authors:  Xinsheng Gu; Jose E Manautou
Journal:  Drug Metab Rev       Date:  2010-08       Impact factor: 4.518

6.  Induction of MRP/GS-X pump and cellular resistance to anticancer prostaglandins.

Authors:  K Akimaru; M T Kuo; K Furuta; M Suzuki; R Noyori; T Ishikawa
Journal:  Cytotechnology       Date:  1996       Impact factor: 2.058

7.  The effect of rifampin treatment on intestinal expression of human MRP transporters.

Authors:  M F Fromm; H M Kauffmann; P Fritz; O Burk; H K Kroemer; R W Warzok; M Eichelbaum; W Siegmund; D Schrenk
Journal:  Am J Pathol       Date:  2000-11       Impact factor: 4.307

8.  Expression of multidrug resistance protein gene in patients with glioma after chemotherapy.

Authors:  T Abe; T Mori; Y Wakabayashi; M Nakagawa; S P Cole; K Koike; M Kuwano; S Hori
Journal:  J Neurooncol       Date:  1998-10       Impact factor: 4.130

9.  Sulfinosine enhances doxorubicin efficacy through synergism and by reversing multidrug resistance in the human non-small cell lung carcinoma cell line (NCI-H460/R).

Authors:  Milica Pesić; Tijana Andjelković; Jasna Banković; Ivanka D Marković; Ljubisa Rakić; Sabera Ruzdijić
Journal:  Invest New Drugs       Date:  2008-05-21       Impact factor: 3.850

10.  A new aspect on glutathione-associated biological function of MRP/GS-X pump and its gene expression.

Authors:  T Ishikawa; M T Kuo; K Furuta; M Suzuki
Journal:  Cytotechnology       Date:  1998-09       Impact factor: 2.058

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.